Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was THB 1,082.22 million compared to THB 615.18 million a year ago. Revenue was THB 1,087.97 million compared to THB 623.54 million a year ago. Net income was THB 91.02 million compared to THB 65.16 million a year ago. Basic earnings per share from continuing operations was THB 0.29 compared to THB 0.22 a year ago.